Donepezil Hydrochloride
Donepezil belongs to a group of medications called acetylcholinesterase inhibitors.
It is used to treat mild to moderate Alzheimer's disease symptoms, including increasing memory loss, disorientation, and behavioral changes.
As a result, people with Alzheimer's disease have increasing difficulty performing everyday activities.
Donepezil is intended for use in adults only.
Before starting Donatine, consult your doctor or pharmacist if you have or have had:
Women should also inform their doctor if they are pregnant or think they may be pregnant.
Donatine is not indicated for use in children and adolescents (under 18 years of age).
Tell your doctor or pharmacist about all medications you are currently taking or have recently taken, as well as any medications you plan to take.
It is especially important to inform your doctor about taking any of the following medications:
If you are scheduled to have surgery that requires general anesthesia, inform your doctor and anesthesiologist that you are taking Donatine, as it may affect the amount of anesthetic needed.
Donatine can be used in patients with kidney or mild to moderate liver impairment. Inform your doctor if you have kidney or liver disease.
Patient with severe liver impairment should not take Donatine.
Patient should provide their doctor or pharmacist with the name of their caregiver. The caregiver will help the patient take the medication as directed by the doctor.
Food does not affect the absorption of Donatine.
Do not drink alcohol while taking Donatine, as it may affect the medication's action.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, consult your doctor or pharmacist before taking this medication.
Women taking Donatine should not breastfeed.
Alzheimer's disease may impair your ability to drive or operate machinery; therefore, do not perform these activities until your doctor determines it is safe.
The medication may cause drowsiness, dizziness, and muscle cramps. If these symptoms occur, do not drive or operate machinery.
This medication contains lactose. If you have been told by your doctor that you have an intolerance to some sugars, consult your doctor before taking Donatine.
Always take this medication exactly as your doctor or pharmacist has told you.
In case of doubt, consult your doctor or pharmacist.
Typically, treatment starts with 5 mg (one white tablet) once daily, in the evening before bedtime.
After one month, your doctor may recommend increasing the dose to 10 mg (one yellow tablet) once daily, in the evening before bedtime.
If you experience unusual dreams, nightmares, or difficulty sleeping (see section 4), your doctor may recommend taking Donatine in the morning.
Take Donatine before bedtime, with a glass of water.
The dose of the tablet may be changed depending on the duration of treatment and your doctor's recommendations. The maximum recommended dose is 10 mg once daily, in the evening before bedtime.
Always follow your doctor's or pharmacist's instructions on how and when to take the medication. Do not change the dose yourself.
Your doctor or pharmacist will tell you how long to continue taking the tablets. From time to time, you should consult your doctor to reassess your symptoms and treatment.
If you have taken more than the recommended dose of the medication, immediately inform your doctor or go to the nearest hospital. Always take the tablets and packaging with you, so the doctor knows what medication you have taken.
Symptoms of overdose may include: nausea (vomiting), vomiting, salivation, sweating, slow heart rate, low blood pressure (feeling of emptiness in the head or dizziness when standing up), breathing difficulties, collapse, and seizures or convulsions.
If you miss a dose, take the next dose at the usual time. Do not take a double dose to make up for the missed tablet.
If you have missed taking the medication for more than a week, consult your doctor before restarting treatment.
Do not stop taking the medication unless your doctor tells you to. After stopping treatment, the beneficial effects of Donatine will gradually decrease.
If you have any further doubts about taking this medication, consult your doctor or pharmacist.
Like all medications, Donatine can cause side effects, although not everybody gets them.
The following side effects have been reported in patients taking Donatine.
Tell your doctor immediately if you experience any of the following side effects. You may need urgent medical attention.
If you experience any side effects, including any not listed in this leaflet, tell your doctor or pharmacist. You can also report side effects directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181C
02-222 Warsaw
tel.: + 48 22 49 21 301
fax: + 48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
You can also report side effects to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of this medication.
Keep the medication out of sight and reach of children.
Do not use this medication after the expiry date stated on the carton and blister pack (EXP). The expiry date refers to the last day of the month.
There are no special storage instructions for this medication.
Medications should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medications no longer needed. This will help protect the environment.
The active substance of Donatine is donepezil hydrochloride. Each film-coated tablet contains donepezil hydrochloride equivalent to 5 mg / 10 mg of donepezil hydrochloride.
The other ingredients are:
Core:lactose monohydrate, corn starch, microcrystalline cellulose, low-substituted hydroxypropyl cellulose, magnesium stearate.
For 5 mg tablets: Hypromellose (E464), titanium dioxide (E171), macrogol 400, talc (E553b)
For 10 mg tablets: Hypromellose (E464), titanium dioxide (E171), macrogol 400, talc (E553b), yellow iron oxide (E172).
Donatine is available in 5 mg and 10 mg film-coated tablets.
5 mg film-coated tablets: are white or almost white, round with a diameter of approximately 7.14 mm, biconvex with beveled edges and engraved with "5" on one side and smooth on the other.
10 mg film-coated tablets: are yellow, round with a diameter of approximately 8.73 mm, biconvex with beveled edges and engraved with "10" on one side and smooth on the other.
Donatine tablets are available in cardboard boxes with blisters of PVC/Aluminum in packs of 7, 10, 28, 30, 50, 56, 60, 84, 98, and 120 tablets or in HDPE bottles containing 100 tablets.
Not all pack sizes may be marketed.
Polpharma S.A.
Pelplińska 19, 83-200 Starogard Gdański
Accord Healthcare Polska Sp. z o.o.
Lutomierska 50
95-200 Pabianice
Member State | Medication Name |
Bulgaria | Донепезил Акорд 5 mg / 10 mg филмирани таблетки |
Czech Republic | Donepezil Accord 5 mg / 10 mg potahované tablety |
Estonia | Donepezil Accord |
Hungary | Donepezil Accord 5 mg / 10 mg filmtabletta |
Latvia | Donepezil Accord 5 mg / 10 mg apvalkotās tabletes |
Lithuania | Donepezil Accord 5 mg / 10 mg plėvele dengtos tabletės |
Poland | Donatine |
Romania | Donepezil Accord 5 mg / 10 mg comprimate filmate |
Slovakia | Donepezil Accord 5 mg / 10 mg filmom obalené tablety |
Slovenia | Donepezilijev klorid Accord 5 mg / 10 mg filmsko obložene tablete |
Sweden | Donepezil Accord 5 mg / 10 mg filmdragerade tabletter |
Austria | Donepezil Accord 5 mg /10 mg Filmtabletten |
Cyprus | Donepezil Accord 5 mg / 10 mg επικαλυμμένα με λεπτό υμένιο δισκία |
Denmark | Donepezilhydrochlorid Accord 5 mg / 10 mg filmovertrukne tabletter |
Finland | Donepezil Accord 5 mg / 10 mg kalvopäällysteinen tabletti/ filmdragerade tabletter |
Ireland | Donepezil 5 mg /10 mg Film-coated Tablets |
Italy | Donepezil Accord 5 mg / 10 mg Compresse Rvestite Con Film |
Malta | Donepezil 5 mg / 10 mg Film-coated Tablets |
Norway | Donepezil Accord 5 mg / 10 mg Filmdrasjerte tabletter |
United Kingdom (Northern Ireland) | Donepezil Hydrochloride 5 mg / 10 mg Film-coated Tablets |
Date of Last Revision of the Leaflet:November 2023
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.